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ABSTRACT
Vaccinia virus is responsible for a zoonosis that usually affects cattle and human beings in Brazil. The 
initial clinical signs of the infection are focal red skin areas, fever, and general symptoms similar to 
those of a cold. Then, pustules and ulcerated lesions surrounded by edema and erythema follow, as 
well as local lymphadenopathy that can last for weeks. Cure and healing of the lesions occur over 
several weeks, leaving a typical scar in the skin of people and animals affected. The infection defi ni-
tive diagnosis is made through morphological characterization of the virus by use of electron micro-
scopy, followed by PCR for specifi c viral genes. Since 1963, circulating orthopoxviruses in infectious 
outbreaks in several regions of Brazil have been reported. Later, the etiological agent of those infec-
tions was characterized as samples of Vaccinia virus. In addition, the widespread use of those viruses 
in research laboratories and mass vaccination of militaries have contributed to increase the cases of 
those infections worldwide. Thus, several epidemiological and clinical studies are required, as well 
as studies of viral immunology, public health, and economic impact, because little is known about 
those Vaccinia virus outbreaks in Brazil.
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INTRODUCTION
Poxviruses are epitheliotrophic viruses that 
have in common the tendency to cause skin 
lesions. They are complex viruses that repli-
cate in cell cytoplasm of vertebrate and inver-
tebrate hosts.1
Virions are constituted by a membrane, 
a nucleus, and lateral bodies, with or without 
an envelope. They have an ovoid or rectangu-
lar shape, and their genetic material is a linear 
double-strand DNA molecule, which can en-
code approximately 200 proteins (Figure 1).1-2,4
Of the known poxviruses, a genus stands 
out due to its medical importance and because 
it serves as a model for studying the Orthopox-
virus viral family, which comprises the small-
pox virus and Vaccinia virus (VACV).1-4 
Smallpox was eradicated worldwide in 
1980, after a large vaccination campaign, in 
which Vaccinia virus was used as a vaccinal vec-
tor, due to its high genetic similarity with the 
smallpox virus.5 
Vaccinia virus is responsible for an impor-
tant zoonotic disease affecting cattle and hu-
man beings in Brazil. The human zoonotic 
infections caused by poxviruses are relatively 
rare.6 
However, zoonoses caused by poxviruses 
have occurred in regions far from their en-
demic areas, such as the outbreak of Monkey-
pox (MPXV) in central North-American states 
during May and June 2003, which was the fi rst 
identifi ed out of Africa.7-9 
In Brazil, since 1960, innumerous out-
breaks related to Vaccinia virus have been doc-
umented by several research groups in differ-
ent regions. Based on molecular studies, some 
Figure 1: Illustration of the morphology of the 
Vaccinia virus.
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genetic variations have already been identifi ed in the viruses 
isolated. An especially relevant fi nding was the isolation of 
two genetically different samples of Vaccinia virus from a 
single outbreak in the town of Guarani, in the Brazilian state 
of Minas Gerais.10
The number of human cases and new viruses isolated 
should increase because new epidemic foci have been re-
ported in different areas. It has not been possible to deter-
mine whether Vaccinia virus infections are actually increas-
ing or if reports have only recently begun.11
Episodes of Vaccinia virus infection in people who work 
at research laboratories have already been reported by the 
Center for Disease Control and Prevention (CDC), contrib-
uting to increase the number of infection cases.12 The virus 
infection has occurred both in individuals previously vac-
cinated in childhood,13-14 and in people never vaccinated 
Table 1. Clinical manifestations, viral diagnosis, and transmission of Vaccinia virus 
 Clinical   Viral  Transmission
 manifestations  diagnosis  
Local Start: focal red areas Morphologic Inoculation of Animals Transmission
 In a few days:   samples of lesions  among animals
 pustules, edema and   and crusts into  occurs mainly
 erythema in hands   allantochorionic  through the
 and forearms.6,11,25  membrane.  milker’s hands or
 After approximately   Viral propagation  mechanical
 12 days: ulcerated,   in VERO cells  milking equipment.
 necrotic and painful   and visualization  Viral penetration
 lesions.6,11,25   of the viral  occurs through
 A few days later,   particles through  preexisting lesions
 most lesions heal   transmission  in cows’ teats.11,27,32
 forming crusts.  electron
 Approximately four   microscopy.11,23,27-28
 weeks after lesion 
 start: cure.
 Local 
 lymphadenopathy 
 that can last 20 
 days.6,11,25
 Secondary bacterial 
 infections can occur 
 in sites of original lesions.26    
Systemic Fever, headache, Molecular PCR of marking Human The disease is
 muscle ache, nausea  genes: thymidine beings transmitted from
 (occasionally) that begin  kinase (TK),   animals to humans
 eight days after  vaccinia virus  through contact
 the appearance of  growth factor (VGF),  with the lesions
 the lesions.6,11,25  hemagglutinin  in cow’s teats.33
   (HA).11,27,29  
    Polymorphism of
   the restriction
   profile of ati
   gene.6,30 Real-time
   PCR of ha gene, by
   using SYBR Green.31
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before.15 Transmission usually occurs through accidental 
inoculation of Vaccinia virus through lesions in fi ngers and 
eyes, or through auto-inoculation.13-16 
In addition to the cases of laboratory infection, cases 
from person-to-person contamination have been reported. 
Such cases are closely related to the vaccination of militar-
ies against Smallpoxvirus.17-18 Ten cases of infection by those 
viruses presumably transmitted through sexual contact have 
been reported in association with vaccination programs in 
the USA and Israel.19-21 
Moreover, one case of vaccinia infection has been re-
ported in a pregnant woman bitten by a dog previously vac-
cinated against rabies with a recombinant Vaccinia virus.22
Clinical signs, transmission, and viral diagnosis
Vaccinia virus infections can be characterized as occupa-
tional zoonotic infections because they occur in human be-
ings who work directly with cattle, the milkers.23 A fact of 
great relevance for public health is that physicians and other 
health care professionals have diffi culty in diagnosing and 
managing these infections.24
The clinical manifestations, transmission, and viral diag-
nosis are shown in Table 1.
Vaccinia virus outbreaks in Brazil
Vaccinia virus outbreaks usually occur in small rural proper-
ties, with little infrastructure, and surrounded by woods. In 
most of these places, milking is performed manually, with-
out the adoption of biosafety measures. These factors are 
believed to contribute to virus dissemination from cattle to 
milkers and vice-versa.23
This zoonosis seems to occur seasonally, mainly in the 
dry season, from July to September. Dry weather conditions 
seem to favor disease appearance and dissemination, since it 
contributes to dry cows’ teats and milkers’ hands, enabling 
the occurrence of lesions that cause the virus transmission 
from animals to men and vice-versa.33 
Poxviruses isolated in Brazil
In South America a few studies on the isolation of poxvi-
rus have been published since the eradication of smallpox. 
Some have reported outbreaks caused by Parapoxvirus in 
sheep and goats, and the virus isolation from wild or do-
mestic animals.11
However indications that members of the Orthopoxvirus 
genus could be circulating actively in wild regions have been 
reported in Brazil since 1963.28-29 In the 1960s and 1970s, the 
Brazilian govern carried out several campaigns of epidemio-
logical surveillance in several rural areas of the country aim-
ing at investigating the circulation of unknown viral agents 
and also the isolation of such new agents.29
Studies conducted from 1999 to 2007 in municipalities 
of Cantagalo, Cordeiro, Aperibé, Santo Antonio de Pádua, 
Cambuci, and Miracema have reported several cases of Vac-
cinia virus infection affecting both bovine animals and hu-
man beings.34
Several viruses isolated in Brazil in different regions after 
outbreaks of bovine smallpox are listed below. A summary 
containing viral samples isolated, hosts, and places of the 
outbreaks of Vaccinia virus infection are shown in Figure 2.
BeAn virus 58058: Belém Vaccinia virus
The BeAN virus 58058 (BAV) was isolated in 1963 from the 
blood of a rodent of the Oryzomis genus in the tropical rain 
forest, in the region of Belém-do-Pará. After morphologic 
and molecular analyses, BAV was included in the Poxviri-
dae family, considered a member of the Orthopoxvirus ge-
nus and a variant of Vaccinia virus, and denominated Belém 
Vaccinia virus.28-29 
In addition, the type-A inclusion body (ati) gene could 
not be amplifi ed through PCR, indicating its probable de-
letion. The IFN-IFN-α/βR gene was identifi ed in the BAV 
genome, which showed a 99% identity with the B18R gene 
of the VACV-WR sample, a gene related to the evasion of the 
host immune system.35
Figure 2: Isolated viral samples, hosts, and places of the outbreaks of Vaccinia virus infection. *The SPAn232 virus was initially 
isolated in 1965 and classified as Cotia virus (LOPES et al. 1965).23
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SPAn232 virus (SPAnv)
The SPAn232 virus (SPAnv) was initially isolated in 1961 
from sentinel rats in the Cotia forest in the state of São Pau-
lo.36 The virus was re-isolated several times and suggested to 
be a recombinant of Leporipoxvirus and Orthopoxvirus.37-39 It 
was originally grouped among the Cotia virus, but, after ge-
netic analyses, it was considered a variant of Vaccinia virus. 
The tk, vgf, and ati genes were amplifi ed and identifi ed in 
genome of SPAnV, and showed a 99% similarity with cor-
relate genes in VACV-WR .29
Cantagalo virus
The Cantagalo virus (CTGV) was isolated from cattle and 
milkers in 1999, during an exanthematic outbreak, in farms 
of the municipality of Cantagalo, southwestern region of the 
state of Rio de Janeiro. Morphologic and molecular evidence 
has confi rmed that CTGV was a Vaccinia virus variant.27,40
After molecular analyses of the ha gene, a close relation 
of Cantagalo virus and VACV used in vaccination campaigns 
against smallpox in Brazil has been demonstrated.27 It has 
been suggested that this sample escaped into the wild, estab-
lishing several cycles of transmission in one or more hosts, 
accumulating polymorphisms, reemerging, then, as Canta-
galo virus in cattle and milkers.27,40
From October 2001 to July 2003, the Instituto Adolfo 
Lutz received 74 samples suggesting Vaccinia virus infec-
tion, from regions of the Brazilian states of São Paulo, Minas 
Gerais, and Goiás. Molecular analyses have categorized them 
as 99.9% similar to Cantagalo virus, differing only by a single 
nucleotide in position 616.41
Muriaé virus
In August 2000, an outbreak affecting cattle and milkers oc-
curred in several farms of dairy cattle in the state of Minas 
Gerais. One virus was isolated and denominated Muriaé vi-
rus (MURV).24
During molecular characterization, when amplifying the 
ha gene, a deletion of 18 nucleotides was observed, allow-
ing this virus introduction in the group of PSTV,23 ARAV,11 
GP2V,10 and CTGV.27 Despite these similarities, Muriaé virus 
had unique characteristics that allowed its differentiation 
from other samples of VACV.24 
Passatempo virus
The Passatempo virus (PSTV) was isolated and identifi ed af-
ter an outbreak in 2003, in the towm of Passa-Tempo, Minas 
Gerais. During that outbreak, cows and milkers had lesions 
similar to those observed during other Vaccinia virus out-
breaks in Brazil. When analyzing the blood of patients, anti-
bodies against VACV–WR were identifi ed.23
That Vaccinia virus variant, denominated Passatempo vi-
rus, has a deletion of 18 nucleotides in ha gene, which repre-
sents a genetic signature of some samples found in Brazil.23
Belo Horizonte virus
The Belo Horizonte virus (VBH) was isolated from an out-
break in mice of the facilities of the Biological Sciences 
Institute (ICB) of the Federal University of Minas Gerais 
(UFMG), in the state of Minas Gerais. The mice were 
brought from the University of Campinas, São Paulo, and 
seemed healthy upon their arrival at the UFMG. A few days 
later, some animals died and others showed skin lesions. The 
virus isolated from the clinical samples was a variant of Vac-
cinia virus, denominated Belo Horizonte virus.42
The origin of the Belo Horizonte virus remains un-
known, since there is no research in the city of Campinas 
involving poxvirus. Those mice might have been contami-
nated by other animals of the nursery of ICB of UFMG, 
where some colonies of mice from other places are re-
ceived. However, it is practically impossible to discover the 
virus actual origin. However, the ubiquitous circulation of 
different Vaccinia virus strains in Brazil, both from wild 
or veterinary origins, suggests that epidemiological studies 
are extremely important.42
Araçatuba virus
In 1999, in the city of Araçatuba, São Paulo, a virus was iso-
lated after an exanthematic outbreak. The infection affected 
cattle and one milker, who developed approximately 10 le-
sions in his hands and arms. No similar episode had previ-
ously occurred in that farm.11 
The isolated virus was a Vaccinia virus variant, and was 
called Araçatuba virus (ARAV). It had a deletion identical 
to that of Cantagalo virus.11 It is worth emphasizing that 
similar genetic signatures occurred in the municipality 
of Cantagalo, located approximately 850 km to the east 
of Araçatuba, and in the town of Muriaé, 850 km to the 
north of Araçatuba, creating speculations about the origin 
of these viruses.11 
Guarani virus
In October 2001, there was an outbreak in the town of Gua-
rani, Minas Gerais, in the southeastern region of the coun-
try. An epidemiological study was carried out in the affected 
region and involved 72 properties. The study reported that 
1,020 milking cows had lesions in their teats. Human cases 
of this disease were identifi ed in 83% of the farms, and ap-
proximately 110 individuals were infected. In some farms, 
the milkers reported person-to-person transmission.10
For laboratory diagnosis and viral isolation, samples 
from the dry crusted lesions of two cows were collected. 
Each cow belonged to a different farm, approximately 10 km 
apart. Two viruses were isolated and denominated Guarani 
P1 virus (GP1V) and Guarani P2 virus (GP2V). Although 
isolated during the same outbreak and at the same time in 
neighboring farms, the GP1V and GP2V showed suffi cient 
genetic divergences to be placed at different sites in the phy-
Signs, diagnosis, and report of Vaccinia virus infection
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logenetic tree. While GP2V was placed with other samples 
of VACV isolated from bovine outbreaks of Vaccinia virus 
(ARAV, CTGV e PSTV), GP1V was placed with VACV-WR 
and VBH that are not associated with bovine outbreaks.10 
These results indicate that there are genetically different 
populations of VACV circulating in the country and even in 
the same infectious outbreak. There are no conclusive stud-
ies on the actual origin of the Brazilian Vaccinia virus.
FINAL CONSIDERATIONS
Vaccinia virus infections are extremely relevant for public 
health and dairy economy in Brazil, although little is known 
about the virus ﬂ ow in the wild and its natural hosts. It is 
diffi cult to defi ne whether such infections have actually been 
increasing or if reporting has only recently started. In addi-
tion, health care professionals have diffi culty in diagnosing 
and managing such infections. 
Thus, implementation of educational strategies with 
health professionals and milkers who work in affected re-
gions is required. For health care professionals, these strat-
egies should be directed to the clinical identifi cation and 
therapeutic management of infected patients. For milkers, 
the educational practices should emphasize biosafety aim-
ing at preventing their contamination with the Vaccinia vi-
rus and reducing crossed infection in cattle. In addition, geo-
processing studies aiming at outlining the virus infectious 
ﬂ ow are extremely important for the creation of health care 
strategies to decrease infection propagation, both among 
cattle and from cattle to human beings. Furthermore, sev-
eral epidemiological and clinical studies are required, as well 
as studies of viral immunology, public health, and economic 
impact, because little is known about Vaccinia virus out-
breaks in Brazil. 
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